The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
120934583 12093458 3 F 20151209 20160712 20160219 20160719 EXP FR-AMGEN-FRASP2016017663 AMGEN 39.00 YR A F Y 0.00000 20160719 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
120934583 12093458 1 PS XGEVA DENOSUMAB 1 Unknown 120 MG, QMO 125320 120 MG SOLUTION FOR INJECTION /month
120934583 12093458 2 SS TRASTUZUMAB EMTANSINE ADO-TRASTUZUMAB EMTANSINE 1 Intravenous (not otherwise specified) 288 MG, Q3WK 1147415 0 288 MG Q3W
120934583 12093458 3 SS CAPECITABINE. CAPECITABINE 1 Oral 1300 MG, BID 0 1300 MG BID
120934583 12093458 4 SS CAPECITABINE. CAPECITABINE 1 Oral 1300 MG, BID 0 1300 MG BID
120934583 12093458 5 SS CACIT D3 CALCIUMCHOLECALCIFEROL 1 Unknown 2 DF, BID 0 2 DF BID
120934583 12093458 6 C TRAMADOL. TRAMADOL 1 Oral 8 DF TABLETS, UNK 0 8 DF
120934583 12093458 7 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 Oral 3 DF TABLETS, UNK 0 3 DF
120934583 12093458 8 C SPASFON PHLOROGLUCINOL 1 Oral 6 TABLETS, UNK 0 6 DF
120934583 12093458 9 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 40 MG, UNK 0 40 MG
120934583 12093458 10 C OROCAL D3 CALCIUM CARBONATECHOLECALCIFEROL 1 Oral 2 DF, TABLETS UNK 0 2 DF
120934583 12093458 11 C LOVENOX ENOXAPARIN SODIUM 1 4000 IU, QD 0 4000 IU QD
120934583 12093458 12 C ACUPAN NEFOPAM HYDROCHLORIDE 1 20 MG, UNK 0 20 MG
120934583 12093458 13 C FORLAX POLYETHYLENE GLYCOL 4000 1 2 SACHET, QD 0 QD
120934583 12093458 14 C LYRICA PREGABALIN 1 150 MG, UNK 0 150 MG QD
120934583 12093458 15 C ROCEPHINE CEFTRIAXONE SODIUM 1 Intravenous (not otherwise specified) UNK 0
120934583 12093458 16 C ZOPHREN ONDANSETRON 1 8 MG, UNK 0 8 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
120934583 12093458 1 Product used for unknown indication
120934583 12093458 2 HER-2 positive breast cancer
120934583 12093458 3 HER-2 positive breast cancer
120934583 12093458 5 Bone cancer metastatic

Outcome of event

Event ID CASEID OUTC COD
120934583 12093458 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
120934583 12093458 Abdominal pain
120934583 12093458 Abdominal pain upper
120934583 12093458 Headache
120934583 12093458 Intestinal obstruction
120934583 12093458 Nausea
120934583 12093458 Pyrexia
120934583 12093458 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
120934583 12093458 1 20150923 0
120934583 12093458 2 20151028 0
120934583 12093458 3 20151028 0
120934583 12093458 4 20151028 0
120934583 12093458 5 20151028 0
120934583 12093458 6 20160121 0
120934583 12093458 7 20160121 0
120934583 12093458 8 20160121 0
120934583 12093458 9 20160121 0
120934583 12093458 10 20160121 0
120934583 12093458 11 20160121 20160125 0
120934583 12093458 12 20160121 20160125 0
120934583 12093458 13 20160121 0
120934583 12093458 14 20160121 0
120934583 12093458 15 20160110 0
120934583 12093458 16 20151028 20151230 0